EE478 A budget impact analysis of introducing filgotinib as a first-line treatment for moderate to severe ulcerative colitis in Greece

Nomikos, N., Naoum, P., Athanasakis, K. and Kyriopoulos, I ORCID: 0000-0002-3932-8228 (2024) EE478 A budget impact analysis of introducing filgotinib as a first-line treatment for moderate to severe ulcerative colitis in Greece. Value in Health, 27 (12 Supplement). S149. ISSN 1098-3015

Full text not available from this repository.

• https://www.webofscience.com/api/gateway...

Item Type:	Article
Divisions:	Health Policy
Subjects:	R Medicine > RA Public aspects of medicine R Medicine > RM Therapeutics. Pharmacology
Date Deposited:	25 Feb 2025 10:03
Last Modified:	01 Mar 2025 04:26
URI:	http://eprints.lse.ac.uk/id/eprint/127401

Actions (login required)

View Item